Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

497 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of Scanner Manufacturer, Endorectal Coil Use, and Clinical Variables on Deep Learning-assisted Prostate Cancer Classification Using Multiparametric MRI.
Almeida JG, Rodrigues NM, Castro Verde AS, Mascarenhas Gaivão A, Bilreiro C, Santiago I, Ip J, Belião S, Matos C, Silva S, Tsiknakis M, Marias K, Regge D, Papanikolaou N; ProCAncer-I Consortium. Almeida JG, et al. Among authors: ip j. Radiol Artif Intell. 2025 Jan 22:e230555. doi: 10.1148/ryai.230555. Online ahead of print. Radiol Artif Intell. 2025. PMID: 39841063
Analysis of domain shift in whole prostate gland, zonal and lesions segmentation and detection, using multicentric retrospective data.
Rodrigues NM, Almeida JG, Verde ASC, Gaivão AM, Bilreiro C, Santiago I, Ip J, Belião S, Moreno R, Matos C, Vanneschi L, Tsiknakis M, Marias K, Regge D, Silva S; ProCAncer-I Consortium; Papanikolaou N. Rodrigues NM, et al. Among authors: ip j. Comput Biol Med. 2024 Mar;171:108216. doi: 10.1016/j.compbiomed.2024.108216. Epub 2024 Mar 2. Comput Biol Med. 2024. PMID: 38442555 Free article.
Corrigendum to "Analysis of domain shift in whole prostate gland, zonal and lesions segmentation and detection, using multicentric retrospective data" [Comput. Biol. Med. 17 (2024) 108216].
Rodrigues NM, de Almeida JG, Castro Verde AS, Gaivão AM, Bilreiro C, Santiago I, Ip J, Belião S, Moreno R, Matos C, Vanneschi L, Tsiknakis M, Marias K, Regge D, Silva S; ProCAncer-I Consortium; Papanikolaou N. Rodrigues NM, et al. Among authors: ip j. Comput Biol Med. 2024 May;173:108352. doi: 10.1016/j.compbiomed.2024.108352. Epub 2024 Mar 27. Comput Biol Med. 2024. PMID: 38538433 Free article. No abstract available.
Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation.
Ruff CT, Patel SM, Giugliano RP, Morrow DA, Hug B, Kuder JF, Goodrich EL, Chen SA, Goodman SG, Joung B, Kiss RG, Spinar J, Wojakowski W, Weitz JI, Murphy SA, Wiviott SD, Parkar S, Bloomfield D, Sabatine MS; AZALEA–TIMI 71 Investigators. Ruff CT, et al. N Engl J Med. 2025 Jan 23;392(4):361-371. doi: 10.1056/NEJMoa2406674. N Engl J Med. 2025. PMID: 39842011 Clinical Trial.
497 results